The BECN1 Knockout 769-P Polyclonal Cells product comprises a CRISPR/Cas9-edited polyclonal cell population carrying targeted disruption of the human BECN1 gene in the 769-P cellular background. This genetically heterogeneous knockout model provides a robust loss-of-function system for interrogating Beclin-1-dependent processes without the clonal selection artifacts inherent in single-cell-derived lines. The polyclonal format ensures representation of diverse editing events across the population, making it suitable for bulk assays where average knockout effects are examined. Researchers can employ this tool to assess the functional consequences of BECN1 ablation on autophagy, apoptosis, and tumor cell biology.
The parental 769-P cell line was originally established from a primary clear cell renal cell carcinoma (ccRCC) resected from a 63-year-old female donor. These tumorigenic renal epithelial cells display adherent epithelial morphology and recapitulate key genetic and phenotypic features of ccRCC, including dysregulated hypoxia signaling and metabolic reprogramming. Widely used as an in vitro model for renal cancer research, 769-P cells facilitate investigations into tumor cell proliferation, invasion, and therapeutic responses. The integration of BECN1 knockout into this clinically relevant ccRCC line enables direct examination of autophagic processes within a kidney cancer context.
BECN1 encodes Beclin-1, a core scaffold protein that orchestrates autophagosome biogenesis by assembling the class III phosphatidylinositol 3-kinase (PI3K) complex with partners such as VPS34 (PIK3C3), VPS15, ATG14, UVRAG, or Rubicon. Beclin-1 activity is tightly regulated by upstream nutrient and energy sensors, including mTORC1, AMPK, and ULK1, and is modulated through direct interactions with Bcl-2 and Bcl-XL, linking autophagy to apoptotic signaling. Upon activation, Beclin-1?Ccontaining complexes generate phosphatidylinositol 3-phosphate (PI3P) on nascent phagophores, recruiting effectors like WIPI2 and promoting the ATG5-ATG12-ATG16L1-dependent lipidation of LC3. Consequently, BECN1 disruption impairs autophagic flux, leading to accumulation of p62/SQSTM1 aggregates and damaged organelles, a phenotype implicated in tumorigenesis and drug resistance.
In 769-P ccRCC cells, BECN1 loss-of-function creates a powerful platform to dissect autophagy-dependent survival mechanisms under conditions relevant to renal tumors, such as hypoxia and nutrient deprivation. Since ccRCC frequently exhibits constitutive HIF activation and mTOR pathway dysregulation, BECN1 knockout cells can be utilized to study how autophagy modulates metabolic adaptation, proliferation, and sensitivity to mTOR inhibitors or other targeted agents. The polyclonal knockout population is particularly suited for pooled functional screens and bulk assays, including western blotting for LC3-II and p62 turnover, autophagic flux measurements with chloroquine treatment, and clonogenic survival analyses. Validation of BECN1 disruption is readily achieved through Beclin-1 immunoblotting and complementary RNA-seq profiling.
This knockout model is suited for autophagy-focused studies, including analysis of autophagosome biogenesis, apoptosis-autophagy crosstalk, and ccRCC tumor microenvironment interactions. Representative assays include immunofluorescence for LC3 puncta, annexin V apoptosis assays, MTT viability measurements, and xenograft tumor growth. For additional support, contact Ascent Research.
